Treatment, discontinuation, and psychomotor effects of diazepam in women with generalized anxiety disorder

Journal of Clinical Psychopharmacology

Volumn 16, Issue 3, 1996, Pages 202-207

  Pourmotabbed, Tahere ^a   Mcleod, Daniel R ^a   Hoehn Saric, Rudolf ^a,c   Hipsley, Pamela ^a   Greenblatt, David J ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; PLACEBO;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MENTAL DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SOMATIZATION; WITHDRAWAL SYNDROME;

ADULT; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; DIAZEPAM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; PSYCHOMOTOR PERFORMANCE;

EID: 0029927317     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199606000-00002     Document Type: Article

References (21)

1. Hollister LE, Muller-Oerlinghausen B, Rickels K, Shader RI. Clinical uses of benzodiazepines. J Clin Psychopharmacol 1993;13 [suppl 1]:1S-169S.
2. Fontaine R, Beaudry P, Beauclair L, Chouinard G. Comparison of withdrawal of buspirone and diazepam: a placebo controlled study. Prog Neuropsychopharmacol Biol Psychiatry 1987;11:189-97.
3. Rickels K, Downing R, Schweizer E, Hassman H. Antidepressants for the treatment of generalized anxiety disorder: a placebo-controlled comparison of imipramine, trazodone, and diazepam. Arch Gen Psychiatry 1993;50:884-95.
4. Hoehn-Saric R, McLeod DR, Zimmerli WD. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms. J Clin Psychiatry 1988;49:8:293-301.
5. Power KG, Jerrom DWA, Simpson RJ, Mitchell M. Controlled study of withdrawal symptoms and rebound anxiety after six-week course of diazepam for generalized anxiety. BMJ 1985;290:1246-8.
6. Fontaine R, Chouinard G, Annable L. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment. Am J Psychiatry 1984;141:848-52.
7. McLeod DR, Hoehn-Saric R, Labib AS, Greenblatt DJ. Six weeks of diazepam treatment in normal women: effects on psychomotor performance and psychophysiology. J Clin Psychopharmacol 1988;8:83-99.
8. Idzikowski C, Baddeley AD. Fear and dangerous environments. In: Hockey R, ed. Stress and fatigue in human performance. New York: John Wiley and Sons, 1983:123-41.
9. Lader M. Anxiety reduction and sedation: psychophysiological theory. Br J Pharmacol 1979;7:99S-105S.
10. Zimmermann-Tansella C, Tansella M, Lader M. Psychophysiological performance in anxiety patients treated with diazepam. Prog Neuropsychopharmacology 1979;3:361-8.
11. Spitzer RL, Williams JEW, Gibbon M. Instruction manual for the structured clinical interview for DSM-III-R (SCID, 4/1/87 revision). New York: Biometrics Research Department, New York State Psychiatric Institute, 1987.
12. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-5.
13. Lipman RS. Differentiating anxiety and depression in anxiety disorders: use of rating scales, Psychopharmacol Bull 1982;18:69-77.
14. Spielberger GS, Gorsuch RL, Lushene RE. Manual for the State Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1970.
15. Locniskar A, Greenblatt DJ, Harmatz JS, Shader RI. Bioinequivalence of a generic brand of diazepam. Biopharm Drug Dispos 1989;10:597-605.
16. Hoehn-Saric R. Characteristics of chronic anxiety patients. In: Klein DF, Rabkin JG, eds. Anxiety: new research and changing concepts, New York: Raven Press, 1981:399-409.
17. Lipman RS, Covi L, Shapiro AK The Hopkins Symptoms Checklist (HSCL): factors derived from the HSCL-90. J Affect Disord :1979;1:9-24.
18. McLeod DR, Griffiths RR, Bigelow GE, Yingling J. An automated version of the digit-symbol substitution test (DSST). Behav Res Methods Instrum 1982;14:463-6.
19. Greenhouse SW, Geisser S. On methods in the analysis of profile data Psychometrika 1959;24:95-112.
20. Linnoila M, Erwin CW, Brendle A, Simpson D. Psychomotor effects of diazepam in anxious patients and healthy volunteers. J Clin Psychopharmacol 1983;3:88-96.
21. Roy-Byrne PP, Dager SR, Cowley DS, Vitaliano P, Dunner DL. Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam. Am J Psychiatry 1989;146:860-5.